IDN Formulary Insights
Support Effective IDN Segmentation and Targeting
- Inform Account-Level Strategy for Integrated Delivery Networks (IDNs): Leverage detailed IDN insights to develop targeted account strategies and optimize market access planning.
- Understand Formulary Coverage and Preferences: Gain visibility into formularies, clinical pathways, decision-making and contracting to support smarter positioning.
- Gain Insights into Contracting Willingness: Assess contracting flexibility and payer behavior across key target accounts to inform strategies.
- Access Hard-to-Find Formulary Data from Complex Entities: Unlock difficult-to-obtain formulary and coverage data from complex IDNs and healthcare entities.
Access Hard-to-Find Formulary Data—All in One Place
What Our Clients Are Saying
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
How We Can Help
MMIT delivers formulary insights powered by an industry-leading panel of pharmacy decision-makers across integrated delivery systems (IDNs). Representing every U.S. region and all levels of IDN integration, this panel provides comprehensive, real-world perspectives on coverage, access, and payer decision-making.
Formulary Insights provides clear visibility into what therapies are covered and preferred across IDNs, helping your team understand how formulary decisions are made within complex health systems.
By delivering actionable formulary data at the account level, Formulary Insights helps teams refine targeting, prioritize high-impact accounts, and engage payers with greater relevance and confidence.
Formulary Insights surfaces hard-to-access formulary information from complex and fragmented health systems, giving teams a more complete picture of coverage and preference.
Solutions to Support Your Strategy
Enhance Formulary Insights with related solutions that provide broader visibility into payer behavior, treatment patterns, and access dynamics. This enables your team to move from insight to confident, informed action.
Message Monitor
Use Message Monitor to capture key payer and IDN decision-makers’ insights around brand perception so you can better position your product against the competition.
Biologics and Injectables Index
Our Biologics and Injectables Index helps you access therapeutic area specific data about payer management priorities, IDN dynamics, copay programs, and more.
P&T Perspectives
P&T Perspectives provides qualitative and tangible feedback through a simulated P&T session that informs your brand’s strategy and helps you determine how your product—or your competitor’s product—will fare in a real P&T Committee review.
Rapid Response
Improve your brand strategy with Rapid Response’s quick, actionable answers to key business questions among a representative sample of the payer and IDN stakeholders that you care about.
Oncology Index
Leverage the MMIT Oncology Index to synthesize insights into an analysis of payer trends, oncology management, and disruptive market events.